Search

Your search keyword '"Arici, Martina"' showing total 26 results

Search Constraints

Start Over You searched for: Author "Arici, Martina" Remove constraint Author: "Arici, Martina"
26 results on '"Arici, Martina"'

Search Results

5. Selective SERCA2a activator as a candidate for chronic heart failure therapy

6. The long-lasting istaroxime metabolite PST3093 stimulates SERCA2a and reverses disease-induced changes in cardiac function

7. Selective SERCA2a activator as a candidate for chronic heart failure therapy

11. A dynamic clamping approach using in silico IK1 current for discrimination of chamber-specific hiPSC-derived cardiomyocytes

12. Selective SERCA2a stimulation: a new promising therapeutic approach for heart failure treatment

13. Selective SERCA2a stimulation: a new promising therapeutic approach for heart failure treatment

14. Istaroxime metabolite PST3093 selectively stimulates SERCA2a and reverses disease-induced changes in cardiac function

15. Highly Selective SERCA2a Activators: Preclinical Development of a Congeneric Group of First-in-Class Drug Leads against Heart Failure

16. SERCA2a stimulation by istaroxime improves intracellular Ca2+ handling and diastolic dysfunction in a model of diabetic cardiomyopathy

17. Stress-induced premature senescence is associated with a prolonged QT interval and recapitulates features of cardiac aging

18. Liraglutide Preserves CD34 + Stem Cells from Dysfunction Induced by High Glucose Exposure

19. Istaroxime metabolite PST3093 selectively stimulates SERCA2a and reverses disease-induced changes in cardiac function

20. Targeting GRP receptor: design, synthesis and preliminary biological characterization of new non-peptide antagonists of bombesin

21. Structural and Electrophysiological Changes in a Model of Cardiotoxicity Induced by Anthracycline Combined With Trastuzumab

22. SERCA2a stimulation by istaroxime improves intracellular Ca2+ handling and diastolic dysfunction in a model of diabetic cardiomyopathy

23. Liraglutide preserves CD34+ stem cells from dysfunction Induced by high glucose exposure.

24. SERCA2a stimulation by istaroxime improves intracellular Ca2+ handling and diastolic dysfunction in a model of diabetic cardiomyopathy.

25. A dynamic clamping approach using in silico IK1 current for discrimination of chamber-specific hiPSC-derived cardiomyocytes

26. Istaroxime Metabolite PST3093 Selectively Stimulates SERCA2a and Reverses Disease-Induced Changes in Cardiac Function.

Catalog

Books, media, physical & digital resources